Crossref
journal-article
American Chemical Society (ACS)
Journal of Medicinal Chemistry (316)
References
136
Referenced
158
{'key': 'ref1/cit1', 'first-page': '111', 'volume': '56', 'author': 'Lambert D. M.', 'year': '2001', 'journal-title': 'J. Pharm. Belg.'}
/ J. Pharm. Belg. by Lambert D. M. (2001)10.1016/0040-4020(63)85022-X
/ Tetrahedron by Mechoulam R. (1963)10.1021/ja01062a046
/ J. Am. Chem. Soc. by Gaoni Y. (1964)10.1038/346561a0
/ Nature by Matsuda L. A. (1990)10.1038/365061a0
/ Nature by Munro S. (1993)10.1080/02791072.1998.10399689
/ J. Psychoact. Drugs by Calhoun S. R. (1998)10.1111/j.1526-4637.2006.00085.x
/ Pain Med. by Berlach D. M. (2006)10.1126/science.1470919
/ Science by Devane W. A. (1992)10.1016/0006-2952(95)00109-D
/ Biochem. Pharmacol. by Mechoulam R. (1995)10.1126/science.1470919
/ Science by Devane W. A. (1992)10.1038/sj.bjp.0707456
/ Br. J. Pharmacol. by Alexander S. P. H. (2007)10.1016/S0021-9258(18)96775-X
/ J. Biol. Chem. by Bachur N. R. (1966)10.1038/384083a0
/ Nature by Cravatt B. F. (1996)10.1074/jbc.M606646200
/ J. Biol. Chem. by Wei B. Q. (2006)10.1074/jbc.M413473200
/ J. Biol. Chem. by Tsuboi K. (2005)10.1021/jm058183t
/ J. Med. Chem. by Lambert D. M. (2005)10.1038/sj.bjp.0707433
/ Br. J. Pharmacol. by Jhaveri M. D. (2007)10.1073/pnas.94.6.2238
/ Proc. Natl. Acad. Sci. U.S.A. by Giang D. K. (1997)10.1073/pnas.161191698
/ Proc. Natl. Acad. Sci. U.S.A. by Cravatt B. F. (2001)10.1073/pnas.96.21.12198
/ Proc. Natl. Acad. Sci. U.S.A. by Walker J. M. (1999)10.1097/00001756-200210280-00001
/ NeuroReport by Fride E. (2002)10.1523/JNEUROSCI.23-10-04127.2003
/ J. Neurosci. by Veldhuis W. B. (2003)10.1038/sj.bjp.0706755
/ Br. J. Pharmacol. by Shouman B. (2006)10.1016/j.pain.2004.01.022
/ Pain by Lichtman A. H. (2004)10.1172/JCI200419465
/ J. Clin. Invest. by Massa F. (2004)10.1073/pnas.0401292101
/ Proc. Natl. Acad. Sci. U.S.A. by Cravatt B. F. (2004)10.1126/science.1142265
/ Science by Karsak M. (2007)10.1093/sleep/27.5.857
/ Sleep by Huitron-Resendiz S. (2004)10.1038/sj.npp.1301224
/ Neuropsychopharmacology by Varvel S. A. (2007)10.1002/cmdc.200700168
/ ChemMedChem by Lambert D. M. (2007)10.1016/j.phrs.2007.09.002
/ Pharmacol. Res. by Bisogno T. (2007)10.1002/dmrr.764
/ Diabetes Metab. Res. Rev. by Cota D. (2007)10.1002/cbdv.200790157
/ Chem. Biodiversity by Labar G. (2007)10.1111/j.1471-4159.1984.tb12750.x
/ J. Neurochem. by Natarajan V. (1984)10.1016/0006-2952(93)90486-G
/ Biochem. Pharmacol. by Deutsch D. G. (1993)10.1016/S0167-4838(96)00145-8
/ Biochim. Biophys. Acta by Chebrou H. (1996)10.1073/pnas.94.22.11986
/ Proc. Natl. Acad. Sci. U.S.A. by Kobayashi M. (1997)10.1016/S1388-1981(99)00143-2
/ Biochim. Biophys. Acta by Goparaju S. K. (1999)10.1006/bbrc.1999.1524
/ Biochem. Biophys. Res. Commun. by Omeir R. L. (1999)10.1021/bi990637z
/ Biochemistry by Patricelli M. P. (1999)10.1016/S0022-3565(24)37574-3
/ J. Pharmacol. Exp. Ther. by Edgemond W. S. (1998)10.1021/bi991876p
/ Biochemistry by Patricelli M. P. (1999)10.1093/emboj/21.11.2509
/ EMBO J. by Shin S. (2002)10.1016/S0022-2836(02)00886-0
/ J. Mol. Biol. by Labahn J. (2002)10.1126/science.1076535
/ Science by Bracey M. H. (2002)10.1074/jbc.M001607200
/ J. Biol. Chem. by Patricelli M. P. (2000)10.1074/jbc.M604515200
/ J. Biol. Chem. by Yun Y. S. (2006)10.1039/b503887a
/ Chem. Commun. by Lodola A. (2005)10.1021/ja065863s
/ J. Am. Chem. Soc. by Tubert-Brohman I. (2006)10.1021/bi981733n
/ Biochemistry by Patricelli M. P. (1998)10.1016/j.febslet.2004.04.084
/ FEBS Lett. by Bracey M. H. (2004)10.1074/jbc.M605653200
/ J. Biol. Chem. by Mei G. (2007)10.1016/S0006-2952(96)00830-1
/ Biochem. Pharmacol. by Deutsch D. G. (1997)10.1006/bbrc.1997.6000
/ Biochem. Biophys. Res. Commun. by De Petrocellis L. (1997)10.1006/bbrc.1997.6072
/ Biochem. Biophys. Res. Commun. by Deutsch D. G. (1997)10.1006/taap.2001.9342
/ Toxicol. Appl. Pharmacol. by Quistad G. B. (2002)10.1016/j.neuropharm.2006.11.009
/ Neuropharmacology by Zhang D. (2007)10.1038/nbt826
/ Nat. Biotechnol. by Leung D. (2003)10.1016/S0021-9258(17)31599-5
/ J. Biol. Chem. by Koutek B. (1994)10.1021/ja954064z
/ J. Am. Chem. Soc. by Patterson J. E. (1996)10.1016/S0960-894X(00)00528-X
/ Bioorg. Med. Chem. Lett. by Boger D. L. (2000)10.1016/0014-5793(95)01311-3
/ FEBS Lett. by Maurelli S. (1995)10.1021/ja055438j
/ J. Am. Chem. Soc. by Guimaraes C. R. W. (2005)10.1016/S0960-894X(98)00734-3
/ Bioorg. Med. Chem. Lett. by Boger D. L. (1999)10.1006/bbrc.1998.8874
/ Biochem. Biophys. Res. Commun. by Bisogno T. (1998)10.1046/j.1432-1327.1999.00631.x
/ Eur. J. Biochem. by Di Marzo V. (1999)10.1046/j.1471-4159.2000.0742597.x
/ J. Neurochem. by Jarrahian A. (2000)10.1038/sj.bjp.0707145
/ Br. J. Pharmacol. by Maione S. (2007)10.1038/sj.bjp.0704199
/ Br. J. Pharmacol. by Jonsson K.-O. (2001)10.1124/jpet.300.3.984
/ J. Pharmacol. Exp. Ther. by Di Marzo V. (2002)10.1021/jm0209679
/ J. Med. Chem. by Vandevoorde S. (2003)10.1038/sj.bjp.0707326
/ Br. J. Pharmacol. by Wallace V. C. J. (2007)10.1073/pnas.97.10.5044
/ Proc. Natl. Acad. Sci. U.S.A. by Boger D. L. (2000)10.1016/S0960-894X(01)00211-6
/ Bioorg. Med. Chem. Lett. by Boger D. L. (2001)10.1016/j.bmc.2007.11.015
/ Bioorg. Med. Chem. by Maryanoff B. E. (2008)10.1021/ja00031a046
/ J. Am. Chem. Soc. by Edwards P. D. (1992)10.1124/jpet.104.069401
/ J. Pharmacol. Exp. Ther. by Lichtman A. H. (2004)10.1021/jm049614v
/ J. Med. Chem. by Boger D. L. (2005)10.1016/j.bmcl.2004.12.085
/ Bioorg. Med. Chem. Lett. by Leung D. (2005)10.1038/sj.bjp.0706699
/ Br. J. Pharmacol. by Chang L. (2006)10.1021/ja064522b
/ J. Am. Chem. Soc. by Romero F. A. (2006)10.1021/jm0611509
/ J. Med. Chem. by Romero F. A. (2007)10.1021/jm061414r
/ J. Med. Chem. by Hardouin C. (2007)- Apodaca, R.; Breitenbucher, J. G.; Epperson, M. T.; Fried, A. K.; Pippel, D. J.; Seierstad, M.Preparation of Piperidinylbutanoyl Oxazoles as Fatty Acid Amide Hydrolase (FAAH) Modulators. WO 2007061862,2007.
- Apodaca, R.; Breitenbucher, J. G.; Chambers, A. L.; Seierstad, M.; Xiao, W.Preparation of Oxazolyl Piperidinyl Methanones As Modulators of Fatty Acid Amide Hydrolase. WO 2007140005,2007.
10.1021/jm011110z
/ J. Med. Chem. by Adang A. E. P. (2002)10.1021/jm021119g
/ J. Med. Chem. by Tarzia G. (2003)10.1021/jm031140x
/ J. Med. Chem. by Mor M. (2004)10.1002/jms.729
/ J. Mass Spectrom. by Basso E. (2004)10.1016/j.chembiol.2005.08.011
/ Chem. Biol. by Alexander J. P. (2005)10.1038/nm803
/ Nat. Med. by Kathuria S. (2003)10.1124/jpet.104.078980
/ J. Pharmacol. Exp. Ther. by Fegley D. (2005)10.1038/sj.bjp.0706510
/ Br. J. Pharmacol. by Jayamanne A. (2006)10.1016/j.ejphar.2006.07.024
/ Eur. J. Pharmacol. by Haller V. L. (2006)10.1007/s00213-006-0689-4
/ Psychopharmacology (Berlin) by Naidu P. S. (2007)- Abouabdellah, A.; Bartsch-Li, R.; Hoornaert, C.; Ravet, A.Aryl- and Heteroaryl-alkylcarbamates Derivatives, Their Preparation, and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005090292,2005.
- Abouabdellah, A.; Almario Garcia, A.; Hoornaert, C.; Li, A. T.Alkyl(homo)piperazine-carboxylate Derivatives, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005090322,2005.
- Abouabdellah, A.; Almario Garcia, A.; Hoornaert, C.; Lardenois, P.; Marguet, F.Aryl- and Heteroaryl-piperidinecarboxylate Derivatives, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005090347,2005.
- Abouabdellah, A.; Almario Garcia, A.; Froissant, J.; Hoornaert, C.Aryloxyalkylcarbamate Derivatives, Including Piperidine Carbamates, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005077898,2005.
- Abouabdellah, A.; Bas, M.; Dargazanli, G.; Hoornaert, C.; Li, A. T.; Medaisko, F.Dioxane-2-alkylcarbamates, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2004020430,2004.
- Kennett, G. A.; Barratt, L.; Geoffroy, S.; Howes, R.In the Rat Formalin Paw Test, VER-154403, a FAAH Inhibitor, Is Anti-Nociceptive and Increases Peripheral and Central Levels of 2-Arachidonylglycerol. Presented at the 37th Annual Meeting of the Society for Neuroscience,2007.
10.1016/j.bmcl.2007.04.009
/ Bioorg. Med. Chem. Lett. by Sit S. Y. (2007)- Sit, S.Y.; Xie, K.Preparation of Bisarylimidazolyl Fatty Acid Amide Hydrolase Inhibitors for Treatment of Pain. WO 2002087569,2002.
- Sit, S.Y.; Xie, K.; Deng, H.Preparation of (Hetero)aryl Carbamates and Oximes as Fatty Acid Amide Hydrolase Inhibitors. WO 2003065989,2003.
- Sit, S.Y.Presented at National Organic Symposium, Salt Lake City, UT,2005.
10.1021/jm070501w
/ J. Med. Chem. by Myllymaki M. J. (2007)- Ishii, T.; Sugane, T.; Maeda, J.; Narazaki, F.; Kakefuda, A.; Sato, K.; Takahashi, T.; Kanayama, T.; Saitoh, C.; Suzuki, J.; Kanai, C.Preparation of Pyridyl Non-Aromatic Nitrogenated Heterocyclic-1-Carboxylate Ester Derivatives as FAAH Inhibitors. WO 2006088075,2006.
- Dasse, O.; Putman, D.; Compton, T. R.; Parrott, J.Alkylcarbamic Acid Ester Inhibitors of Fatty Acid Amide Hydrolase, and Therapeutic Use. WO 2007079180,2007.
10.1007/s10571-006-9072-6
/ Cell. Mol. Neurobiol. by Dickason-Chesterfield A. K. (2006)10.1021/ja062999h
/ J. Am. Chem. Soc. by Alexander J. P. (2006)- Matsumoto, T.; Kori, M.; Miyazaki, J.; Kiyota, Y.Preparation of Piperidinecarboxamides and Piperazinecarboxamides as Fatty Acid Amide Hydrolase (FAAH) Inhibitors. WO 2006054652,2006.
- Matsumoto, T.; Kori, M.; Kouno, M.Preparation of Piperazine-1-carboxamide derivatives as Brain/Neuronal Cell-Protecting Agents, and Therapeutic Agents for Sleep Disorder. WO 2007020888,2007.
- Apodaca, R.; Breitenbucher, J. G.; Pattabiraman, K.; Seierstad, M.; Xiao, W.Preparation of Thiadiazolylpiperazinecarboxamides as Modulators of Fatty Acid Amide Hydrolase (FAAH).,2007.
{'volume-title': 'Nociception: Taking the Pain out of Drug Discovery', 'year': '2006', 'author': 'Breitenbucher J. G.', 'key': 'ref114/cit114'}
/ Nociception: Taking the Pain out of Drug Discovery by Breitenbucher J. G. (2006)- Apodaca, R.; Breitenbucher, J. G.; Pattabiraman, K.; Seierstad, M.; Xiao, W.Piperazinyl and Piperidinyl Ureas as Modulators of Fatty Acid Amide Hydrolase. WO 2006074025,2006.
10.1021/bi701378g
/ Biochemistry by Ahn K. (2007)10.1007/BF00421212
/ Psychopharmacologia by Torii S. (1973)10.1016/S0960-894X(98)00073-0
/ Bioorg. Med. Chem. Lett. by Patricelli M. P. (1998)10.1016/S0014-5793(97)00061-6
/ FEBS Lett. by Beltramo M. (1997)- Bartolini, W.; Cali, B. M.; Chen, B.; Chien, Y.T.; Currie, M. G.; Milne, T. G.; Pearson, J. P.; Talley, J. J.; Zimmerman, C.COX-2 and FAAH Inhibitors. WO 2005002525,2005.
- Bartolini, W.; Cali, B. M.; Chen, B.; Chen, Y. T.; Currie, M. G.; Milne, G.T.; Pearson, J. P.; Talley, J. J.; Yang, J. J.; Zimmerman, C.Modulators of CRTH2, COX-2 and FAAH. WO 2006036994,2006.
10.1021/jm060394q
/ J. Med. Chem. by Saario S. M. (2006)10.1021/jm050977k
/ J. Med. Chem. by Muccioli G. G. (2006)10.1016/j.bmcl.2006.06.087
/ Bioorg. Med. Chem. Lett. by Michaux C. (2006)10.1038/sj.bjp.0705334
/ Br. J. Pharmacol. by Patel S. (2003)10.1097/00000542-200602000-00012
/ Anesthesiology by Schelling G. (2006)10.1038/sj.bjp.0704113
/ Br. J. Pharmacol. by Holt S. (2001)10.1074/jbc.M501489200
/ J. Biol. Chem. by Hogestatt E. D. (2005)10.1073/pnas.0806121105
/ Proc. Natl. Acad. Sci. U.S.A. by Mileni M. (2008)10.1021/jm701210y
/ J. Med. Chem. by Kimball F. S. (2008)10.1021/jm800136b
/ J. Med. Chem. by Garfunkle J. (2008)10.1016/j.bmcl.2008.01.091
/ Bioorg. Med. Chem. Lett. by Timmons A. (2008)10.1021/jm701631z
/ J. Med. Chem. by Mor M. (2008)10.1016/j.bmcl.2008.07.081
/ Bioorg. Med. Chem. Lett. by Keith J. M. (2008)10.1016/j.bmcl.2008.05.081
/ Bioorg. Med. Chem. Lett. by Urbach A. (2008)- Adams, J.; Behnke, M. L.; Castro, A. C.; Evans, C. A.; Grenier, L.; Grogan, M. J.; Liu, T.; Snyder, D. A.; Tibbitts, T. T.Inhibitors of Fatty Acid Amide HydrolaseWO 2008063300,2008.
Dates
Type | When |
---|---|
Created | 16 years, 9 months ago (Nov. 5, 2008, 6 a.m.) |
Deposited | 6 months, 3 weeks ago (Feb. 2, 2025, 9:12 a.m.) |
Indexed | 1 month ago (July 26, 2025, 5:03 a.m.) |
Issued | 16 years, 9 months ago (Nov. 5, 2008) |
Published | 16 years, 9 months ago (Nov. 5, 2008) |
Published Online | 16 years, 9 months ago (Nov. 5, 2008) |
Published Print | 16 years, 8 months ago (Dec. 11, 2008) |
@article{Seierstad_2008, title={Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors}, volume={51}, ISSN={1520-4804}, url={http://dx.doi.org/10.1021/jm800311k}, DOI={10.1021/jm800311k}, number={23}, journal={Journal of Medicinal Chemistry}, publisher={American Chemical Society (ACS)}, author={Seierstad, Mark and Breitenbucher, J. Guy}, year={2008}, month=nov, pages={7327–7343} }